10318 | HSAP00P0000128509 | -1.869 | 6.428 | -4.979 | 0.000142 | 0.006907 | 1.114 | TNIP1 | TNFAIP3 interacting protein 1 | ENSG00000145901 | 607714 | 10318 | NM_006058 |
10542 | HSAP00P0000021667 | -1.381 | 10.79 | -4.384 | 0.0004763 | 0.01485 | -0.06811 | HBXIP | hepatitis B virus x interacting protein | ENSG00000134248 | 608521 | 10542 | BC062619 |
10663 | HSAP00P0000078722 | 0.8166 | 4.598 | 1.978 | 0.06565 | 0.2835 | -4.733 | CXCR6 | chemokine (C-X-C motif) receptor 6 | ENSG00000172215 | 605163 | 10663 | U73531 |
1487 | HSAP00P0000098368 | -1.5 | 8.09 | -5.073 | 0.0001176 | 0.006147 | 1.298 | CTBP1 | C-terminal binding protein 1 | ENSG00000159692 | 602618 | 1487 | BC011655 |
1488 | HSAP00P0000226318 | -3.219 | 8.663 | -9.102 | 1.116e-07 | 8.781e-05 | 7.99 | CTBP2 | C-terminal binding protein 2 | ENSG00000175029 | 602619 | 1488 | NM_001329 |
1984 | HSAP00P0000336123 | -2.203 | 10.93 | -8.736 | 1.927e-07 | 0.0001223 | 7.479 | EIF5A | eukaryotic translation initiation factor 5A | ENSG00000132507 | 600187 | 1984 | NM_001970 |
200316 | HSAP00P0000416923 | 0.5079 | 12.71 | 1.954 | 0.0687 | 0.2905 | -4.773 | APOBEC3F | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F | ENSG00000128394 | 608993 | 200316 | NM_145298 |
27336 | HSAP00P0000432933 | 0.9608 | 9.431 | 3.662 | 0.002143 | 0.03901 | -1.529 | HTATSF1 | HIV-1 Tat specific factor 1 | ENSG00000102241 | 300346 | 27336 | NM_014500 |
3576 | HSAP00P0000104583 | 2.849 | 4.735 | 5.337 | 6.983e-05 | 0.004423 | 1.807 | IL8 | interleukin 8 | ENSG00000169429 | 146930 | 3576 | NM_000584 |
4986 | HSAP00P0000182361 | 2.055 | 4.61 | 4.673 | 0.0002635 | 0.01024 | 0.5097 | OPRK1 | opioid receptor, kappa 1 | ENSG00000082556 | 165196 | 4986 | NM_000912 |
5478 | HSAP00P0000161566 | -2.619 | 11.27 | -5.297 | 7.558e-05 | 0.004654 | 1.73 | PPIA | peptidylprolyl isomerase A (cyclophilin A) | ENSG00000196262 | 123840 | 5478 | NM_021130 |
60489 | HSAP00P0000416945 | 0.7595 | 3.929 | 2.542 | 0.02192 | 0.1573 | -3.739 | APOBEC3G | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G | ENSG00000239713 | 607113 | 60489 | AK022802 |
6347 | HSAP00P0000342389 | -1.222 | 4.744 | -1.626 | 0.1238 | 0.3895 | -5.278 | CCL2 | chemokine (C-C motif) ligand 2 | ENSG00000108691 | 158105, 182940, 607948, 609423 | 6347 | NM_002982 |
6348 | HSAP00P0000343207 | 1.279 | 9.145 | 2.793 | 0.01316 | 0.1176 | -3.262 | CCL3 | chemokine (C-C motif) ligand 3 | ENSG00000006075 | 182283, 609423 | 6348 | D63785 |
6351 | HSAP00P0000343097 | 0.6062 | 3.821 | 2.601 | 0.01946 | 0.1473 | -3.628 | CCL4 | chemokine (C-C motif) ligand 4 | ENSG00000129277 | 182284 | 6351 | BC027961 |
6598 | HSAP00P0000413001 | -2.021 | 9.197 | -7.035 | 3.032e-06 | 0.0006439 | 4.854 | SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | ENSG00000099956 | 601607, 609322 | 6598 | AK024025 |
6895 | HSAP00P0000264135 | -1.428 | 6.497 | -4.571 | 0.0003242 | 0.01164 | 0.3073 | TARBP2 | TAR (HIV-1) RNA binding protein 2 | ENSG00000139546 | 605053 | 6895 | NM_134323 |
7153 | HSAP00P0000344552 | -2.576 | 8.3 | -5.01 | 0.0001334 | 0.006643 | 1.175 | TOP2A | topoisomerase (DNA) II alpha 170kDa | ENSG00000131747 | 126430 | 7153 | NM_001067 |
7342 | HSAP00P0000076715 | -2.109 | 7.767 | -4.766 | 0.000218 | 0.009079 | 0.6947 | UBP1 | upstream binding protein 1 (LBP-1a) | ENSG00000153560 | 609784 | 7342 | NM_014517 |
7913 | HSAP00P0000135112 | -2.532 | 9.785 | -8.067 | 5.456e-07 | 0.0002258 | 6.496 | DEK | DEK oncogene | ENSG00000124795 | 125264 | 7913 | BX641063 |
9217 | HSAP00P0000403144 | -1.25 | 8.357 | -4.151 | 0.0007722 | 0.02029 | -0.5389 | VAPB | VAMP (vesicle-associated membrane protein)-associated protein B and C | ENSG00000124164 | 182980, 605704, 608627 | 9217 | AK128422 |